Jonathan Faddis Sells 1,694 Shares of Veeva Systems Inc. (NYSE:VEEV) Stock

Veeva Systems Inc. (NYSE:VEEV - Get Free Report) SVP Jonathan Faddis sold 1,694 shares of Veeva Systems stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $230.30, for a total transaction of $390,128.20. Following the completion of the sale, the senior vice president now directly owns 8,061 shares of the company's stock, valued at approximately $1,856,448.30. The trade was a 17.37 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Veeva Systems Stock Up 8.1 %

Shares of Veeva Systems stock traded up $18.79 during trading on Friday, reaching $250.45. 2,898,517 shares of the company were exchanged, compared to its average volume of 973,276. Veeva Systems Inc. has a twelve month low of $165.12 and a twelve month high of $258.93. The business has a 50-day moving average price of $217.50 and a 200-day moving average price of $202.61. The firm has a market capitalization of $40.56 billion, a price-to-earnings ratio of 67.22, a P/E/G ratio of 2.20 and a beta of 0.82.

Wall Street Analyst Weigh In

VEEV has been the subject of several analyst reports. Evercore ISI lifted their price objective on shares of Veeva Systems from $220.00 to $245.00 and gave the company an "in-line" rating in a research note on Friday. StockNews.com upgraded shares of Veeva Systems from a "hold" rating to a "buy" rating in a report on Saturday, November 9th. Scotiabank lifted their target price on shares of Veeva Systems from $235.00 to $240.00 and gave the stock a "sector perform" rating in a report on Friday. Guggenheim lifted their target price on shares of Veeva Systems from $233.00 to $249.00 and gave the stock a "buy" rating in a report on Tuesday, October 1st. Finally, UBS Group lifted their target price on shares of Veeva Systems from $185.00 to $215.00 and gave the stock a "neutral" rating in a report on Monday, August 26th. One analyst has rated the stock with a sell rating, eight have given a hold rating and eighteen have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $254.04.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Oddo BHF Asset Management Sas acquired a new position in Veeva Systems in the third quarter valued at about $11,770,000. Peapack Gladstone Financial Corp lifted its holdings in shares of Veeva Systems by 5.6% in the third quarter. Peapack Gladstone Financial Corp now owns 70,147 shares of the technology company's stock valued at $14,721,000 after purchasing an additional 3,741 shares in the last quarter. Tidal Investments LLC lifted its holdings in shares of Veeva Systems by 77.1% in the third quarter. Tidal Investments LLC now owns 22,330 shares of the technology company's stock valued at $4,686,000 after purchasing an additional 9,724 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Veeva Systems in the third quarter valued at about $168,000. Finally, World Investment Advisors LLC bought a new stake in shares of Veeva Systems in the third quarter valued at about $2,131,000. 88.20% of the stock is owned by institutional investors and hedge funds.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.